| Characteristic | Pharmaceutical sales | Total sales |
|---|---|---|
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
| - | - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Release date
September 2010
Region
Worldwide
Survey time period
2009
Supplementary notes
Converted at average exchange rates of the ECB.
* 2009 acquisition of Wyeth by Pfizer.
** 2009 acquisition of Schering-Plough by Merck.
Citation formats









